Barclays’s Sanofi SNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-900
| Closed | -$43.6K | – | 5404 |
|
|
2025
Q4 | $43.6K | Buy |
900
+800
| +800% | +$39.7K | ﹤0.01% | 4760 |
|
|
2025
Q3 | $4.72K | Buy |
+100
| New | +$4.83K | ﹤0.01% | 5087 |
|
|
2022
Q1 | – | Sell |
-23,800
| Closed | -$1.19M | – | 5548 |
|
|
2021
Q4 | $1.19M | Buy |
+23,800
| New | +$1.18M | ﹤0.01% | 2716 |
|
|
2020
Q2 | – | Sell |
-140,500
| Closed | -$6.14M | – | 6179 |
|
|
2020
Q1 | $6.14M | Sell |
140,500
-4,000
| -3% | -$191K | ﹤0.01% | 1305 |
|
|
2019
Q4 | $7.25M | Buy |
144,500
+46,900
| +48% | +$2.2M | ﹤0.01% | 1652 |
|
|
2019
Q3 | $4.52M | Buy |
97,600
+20,700
| +27% | +$893K | ﹤0.01% | 1946 |
|
|
2019
Q2 | $3.33M | Buy |
76,900
+36,800
| +92% | +$1.56M | ﹤0.01% | 2307 |
|
|
2019
Q1 | $1.78M | Sell |
40,100
-75,400
| -65% | -$3.23M | ﹤0.01% | 2703 |
|
|
2018
Q4 | $5.01M | Buy |
115,500
+32,600
| +39% | +$1.44M | ﹤0.01% | 1602 |
|
|
2018
Q3 | $3.7M | Sell |
82,900
-8,000
| -9% | -$342K | ﹤0.01% | 2137 |
|
|
2018
Q2 | $3.64M | Sell |
90,900
-3,600
| -4% | -$142K | ﹤0.01% | 2003 |
|
|
2018
Q1 | $3.79M | Buy |
94,500
+12,700
| +16% | +$528K | ﹤0.01% | 1843 |
|
|
2017
Q4 | $3.52M | Buy |
81,800
+100
| +0.1% | +$4.61K | ﹤0.01% | 1931 |
|
|
2017
Q3 | $4.07M | Buy |
81,700
+36,800
| +82% | +$1.78M | ﹤0.01% | 1700 |
|
|
2017
Q2 | $2.15M | Buy |
44,900
+13,500
| +43% | +$645K | ﹤0.01% | 2182 |
|
|
2017
Q1 | $1.42M | Sell |
31,400
-60,900
| -66% | -$2.58M | ﹤0.01% | 2406 |
|
|
2016
Q4 | $3.73M | Buy |
92,300
+27,900
| +43% | +$1.1M | ﹤0.01% | 1594 |
|
|
2016
Q3 | $2.46M | Buy |
64,400
+51,600
| +403% | +$2.07M | ﹤0.01% | 1824 |
|
|
2016
Q2 | $536K | Sell |
12,800
-800
| -6% | -$32.8K | ﹤0.01% | 3153 |
|
|
2016
Q1 | $544K | Sell |
13,600
-1,700
| -11% | -$68.3K | ﹤0.01% | 3083 |
|
|
2015
Q4 | $643K | Sell |
15,300
-2,500
| -14% | -$115K | ﹤0.01% | 2995 |
|
|
2015
Q3 | $837K | Sell |
17,800
-20,000
| -53% | -$1.02M | ﹤0.01% | 2901 |
|
|
2015
Q2 | $1.85M | Buy |
37,800
+4,900
| +15% | +$248K | ﹤0.01% | 2281 |
|
|
2015
Q1 | $1.61M | Buy |
32,900
+1,000
| +3% | +$47.8K | ﹤0.01% | 2516 |
|
|
2014
Q4 | $1.44M | Sell |
31,900
-17,500
| -35% | -$849K | ﹤0.01% | 2838 |
|
|
2014
Q3 | $2.77M | Buy |
49,400
+34,100
| +223% | +$1.83M | ﹤0.01% | 2359 |
|
|
2014
Q2 | $811K | Sell |
15,300
-300
| -2% | -$15.9K | ﹤0.01% | 3525 |
|
|
2014
Q1 | $811K | Sell |
15,600
-14,600
| -48% | -$739K | ﹤0.01% | 3477 |
|
|
2013
Q4 | $1.6M | Sell |
30,200
-7,800
| -21% | -$402K | ﹤0.01% | 2901 |
|
|
2013
Q3 | $1.9M | Buy |
38,000
+18,500
| +95% | +$941K | ﹤0.01% | 2643 |
|
|
2013
Q2 | $1M | Buy |
+19,500
| New | +$1.04M | ﹤0.01% | 3347 |
|
Other funds holding SNY
MIP
Barclays's SNY Position: Q1 2026 in Review
Barclays increased its Sanofi (SNY) stake by 10% in Q1 2026, buying an estimated $10.4M and bringing the position to 2,356,559 shares worth $114M. The position accounts for 0.03% of the portfolio, ranked #451.
Barclays first reported a position in SNY in Q2 2013 and has held it in 52 quarters since. 738 funds tracked by Wall St. Rank hold SNY as of Q1 2026.
- Barclays held 2,356,559 shares of Sanofi worth $114M as of Q1 2026.
- Barclays bought 222,503 Sanofi shares in Q1 2026, an estimated $10.4M.
- Sanofi made up 0.03% of Barclays's portfolio in Q1 2026, its #451 holding.
- Barclays first reported a position in Sanofi in Q2 2013 and has held it in 52 quarters since.
- 738 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.
Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.